News
Strides Pharma Science consolidated net profit declines 97.03% in the June 2025 quarter
29-Jul-2025 | 13:40
Sales rise 6.20% to Rs 1119.74 crore
Net profit of Strides Pharma Science declined 97.03% to Rs 99.61 crore in the quarter ended June 2025 as against Rs 3351.47 crore during the previous quarter ended June 2024. Sales rose 6.20% to Rs 1119.74 crore in the quarter ended June 2025 as against Rs 1054.34 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 1119.74 | 1054.34 | 6 |
| OPM % | 19.48 | 17.87 | - |
| PBDT | 179.30 | 128.64 | 39 |
| PBT | 130.41 | 82.12 | 59 |
| NP | 99.61 | 3351.47 | -97 |
Powered by Capital Market - Live News